Synopsis
0
EU WC
0
NDC API
0
VMF
0
Europe
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]INTERMEDIATE SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
56
PharmaCompass offers a list of Ceftizoxime Sodium API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Ceftizoxime Sodium manufacturer or Ceftizoxime Sodium supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Ceftizoxime Sodium manufacturer or Ceftizoxime Sodium supplier.
A Ceftizoxime sodium salt manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Ceftizoxime sodium salt, including repackagers and relabelers. The FDA regulates Ceftizoxime sodium salt manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Ceftizoxime sodium salt API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Ceftizoxime sodium salt manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.
A Ceftizoxime sodium salt supplier is an individual or a company that provides Ceftizoxime sodium salt active pharmaceutical ingredient (API) or Ceftizoxime sodium salt finished formulations upon request. The Ceftizoxime sodium salt suppliers may include Ceftizoxime sodium salt API manufacturers, exporters, distributors and traders.
click here to find a list of Ceftizoxime sodium salt suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.
A Ceftizoxime sodium salt DMF (Drug Master File) is a document detailing the whole manufacturing process of Ceftizoxime sodium salt active pharmaceutical ingredient (API) in detail. Different forms of Ceftizoxime sodium salt DMFs exist exist since differing nations have different regulations, such as Ceftizoxime sodium salt USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Ceftizoxime sodium salt DMF submitted to regulatory agencies in the US is known as a USDMF. Ceftizoxime sodium salt USDMF includes data on Ceftizoxime sodium salt's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Ceftizoxime sodium salt USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Ceftizoxime sodium salt suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Ceftizoxime sodium salt Drug Master File in Japan (Ceftizoxime sodium salt JDMF) empowers Ceftizoxime sodium salt API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Ceftizoxime sodium salt JDMF during the approval evaluation for pharmaceutical products. At the time of Ceftizoxime sodium salt JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Ceftizoxime sodium salt suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Ceftizoxime sodium salt Drug Master File in Korea (Ceftizoxime sodium salt KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Ceftizoxime sodium salt. The MFDS reviews the Ceftizoxime sodium salt KDMF as part of the drug registration process and uses the information provided in the Ceftizoxime sodium salt KDMF to evaluate the safety and efficacy of the drug.
After submitting a Ceftizoxime sodium salt KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Ceftizoxime sodium salt API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Ceftizoxime sodium salt suppliers with KDMF on PharmaCompass.
A Ceftizoxime sodium salt CEP of the European Pharmacopoeia monograph is often referred to as a Ceftizoxime sodium salt Certificate of Suitability (COS). The purpose of a Ceftizoxime sodium salt CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Ceftizoxime sodium salt EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Ceftizoxime sodium salt to their clients by showing that a Ceftizoxime sodium salt CEP has been issued for it. The manufacturer submits a Ceftizoxime sodium salt CEP (COS) as part of the market authorization procedure, and it takes on the role of a Ceftizoxime sodium salt CEP holder for the record. Additionally, the data presented in the Ceftizoxime sodium salt CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Ceftizoxime sodium salt DMF.
A Ceftizoxime sodium salt CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Ceftizoxime sodium salt CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Ceftizoxime sodium salt suppliers with CEP (COS) on PharmaCompass.
Ceftizoxime sodium salt Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Ceftizoxime sodium salt GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Ceftizoxime sodium salt GMP manufacturer or Ceftizoxime sodium salt GMP API supplier for your needs.
A Ceftizoxime sodium salt CoA (Certificate of Analysis) is a formal document that attests to Ceftizoxime sodium salt's compliance with Ceftizoxime sodium salt specifications and serves as a tool for batch-level quality control.
Ceftizoxime sodium salt CoA mostly includes findings from lab analyses of a specific batch. For each Ceftizoxime sodium salt CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Ceftizoxime sodium salt may be tested according to a variety of international standards, such as European Pharmacopoeia (Ceftizoxime sodium salt EP), Ceftizoxime sodium salt JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Ceftizoxime sodium salt USP).
